News for Esperion Therapeutics, Inc. (0IIM.L)

Published at

Mar 3, 2025 2:00 PM

by gurufocus.com

positive

positive

Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia

”“ Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales ”“ ANN ARBOR, Mich., March 03, 2

ESPR CSLN.MX CSLLY CSL.AX CMXHF 0IIM.L

Read more →
Published at

Feb 28, 2025 3:13 PM

by insidermonkey.com

mixed

mixed

12 Best Small Cap Pharma Stocks to Buy Now

Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics of the pharmaceutical ...

ESPR 0IIM.L COLL ANIK

Read more →
Published at

Feb 18, 2025 3:00 PM

by gurufocus.com

positive

positive

Esperion to Report Fourth Quarter and Full Year 2024 Financial Results on March 4

ANN ARBOR, Mich., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Esperion ( ESPR) today announced it will report third quarter 2024 financial results before the market ope

ESPR 0IIM.L

Read more →
Published at

Feb 15, 2025 1:41 AM

by gurufocus.com

positive

positive

BB Biotech AG's Strategic Acquisition of Esperion Therapeutics Shares

On December 31, 2024, BB Biotech AG executed a notable stock transaction by acquiring 750,000 shares of Esperion Therapeutics Inc. This acquisition was made at

IONS.MX IONS ESPR BION.SW BBZA.DE BBAGF 0JDI.L 0IIM.L

Read more →
Published at

Jan 9, 2025 2:10 PM

by manilatimes.net

positive

positive

Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 a.m. ET.

**media[510782]**

ESPR 0IIM.L

Read more →
Published at

Jan 2, 2025 2:33 PM

by manilatimes.net

positive

positive

Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference

**media[504200]**

ESPR 0IIM.L

Read more →
Published at

Jan 2, 2025 2:00 PM

by gurufocus.com

positive

positive

Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference

ANN ARBOR, Mich., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Esperion ( ESPR) today announced that the company will be participating in the webcasted 43rd Annual J.P.

ESPR 0IIM.L

Read more →
Published at

Dec 12, 2024 3:00 PM

by gurufocus.com

positive

positive

Esperion Partners with Neopharm to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Israel

”“ Esperion to Receive an Upfront Payment and Near-Term Milestones Along with Tiered Royalties on Product Sales ”“ ”“ Israel-Based Commercial Organization B

ESPR 0IIM.L

Read more →
Published at

Dec 2, 2024 6:33 PM

by investing.com

positive

positive

Esperion stock soars to 52-week high of $3.41 amid robust gains By Investing.com

Esperion stock soars to 52-week high of $3.41 amid robust gains

MLMAD.PA MLAHC.PA ESPR 0IIM.L

Read more →
Published at

Dec 2, 2024 2:00 PM

by gurufocus.com

positive

positive

Esperion Announces New Drug Submissions in Canada for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Treatments to Reduce LDL-C and Cardiovascular Risk

ANN ARBOR, Mich., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Esperion ( ESPR) today announced that it has filed New Drug Submissions (NDSs) to Health Canada for NEXLET

ESPR 0IIM.L

Read more →
Published at

Nov 26, 2024 2:00 PM

by gurufocus.com

positive

positive

Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia

ANN ARBOR, Mich., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Esperion ( ESPR) today announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka) has submitted a New Drug Ap

ESPR 0IIM.L

Read more →
Published at

Nov 13, 2024 8:08 AM

by seekingalpha.com

positive

positive

Esperion Therapeutics: Growth Initiatives Are Paying Off

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened future revenue streams. See why ESPR stock is a Buy.

ESPR 0IIM.L

Read more →
Published at

Nov 11, 2024 10:28 PM

by gurufocus.com

positive

positive

Regencell Bioscience (RGC) Stock Plummets Amidst Lackluster Financial Performance

Regencell Bioscience Holdings (RGC) experienced a significant stock drop of 5.46%. The stock price fell to $6.54 with a trading volume of 32,386 shares and a tu

SNOA EVTCY EVTA.DE EVT.DE EVOTF EVOK ESPR 0IIM.L

Read more →
Published at

Aug 13, 2024 3:50 AM

by seekingalpha.com

mixed

mixed

Esperion Therapeutics, Inc. (ESPR) Q2 2024 Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:NASDAQ:ESPR) Q2 2024 Earnings Conference Call August 12, 2024 8:00 AM ETCompany ParticipantsAlina Venezia - Director of...

DSNKY DSKYF 4568.T ESPR 0IIM.L

Read more →
Published at

Aug 12, 2024 12:04 PM

by benzinga.com

mixed

mixed

Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket - Ainos (NASDAQ:AIMD)

Shares of Ainos, Inc. AIMD rose sharply in today's pre-market trading after the company announced that it has obtained exclusive licenses for a total of 10 inve...

YMAB SNOA MMAT HUGE.CN HUGE ESPR ANTE AIMD ADAP 0IIM.L NDRAW NDRA HUMA CMAXW CMAX HE

Read more →
Published at

Jul 16, 2024 6:36 PM

by investing.com

mixed

mixed

New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the Lipid Lurkers Inside Their Arteries By Investing.com

New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the Lipid Lurkers Inside Their Arteries

SYNH 0IIM.L ESPR

Read more →
Published at

Jun 28, 2024 2:56 PM

by rttnews.com

mixed

mixed

Pre-market Movers: COSM, CARM, ELTX, NXL, ACCD…

Illinois-based healthcare company Cosmos Health Inc. (COSM) is up over 66 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

NKED.BA NKECL.SN NKE.SN NKE.MX NKE.DE NKE.BA NKE ACCD TKNO PTGX INFN.MX INFN GPACW GPACU GPAC GANX ESPR CRKN ANTE 0IIM.L

Read more →
Published at

Jun 20, 2024 7:26 PM

by benzinga.com

mixed

mixed

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Jabil (NYSE:JBL)

Loading... Loading... Shares of Jabil Inc. JBL fell sharply during Thursday's session following third-quarter results. Jabil reported third-quarter fiscal 202...

VNDA TBLT SMCI RELIW RELI OCUL NYAX.TA NKLA.MX MOLN.SW MLLCF MBIO KAVL HIMX ESPR DXF DMTKW DMTK.MX DMTK BILIN.MX BILI B1IL34.SA 9626.HK 8NI.DE 0QXX.L 0LKB.L 0J5H.L 0IIM.L 0A3R.L TPST PACK NNVC NLSPW NLSP JBL IBRX GMS TRVN SONN AMD.MX AMD.DE AMD A1MD34.SA

Read more →
Published at

Apr 11, 2024 7:33 PM

by benzinga.com

mixed

mixed

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session - Aesthetic Medical Intl (NASDAQ:AIH), Acorda Therapeutics (NASDAQ:ACOR)

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

VERBW VERB SPRCY SPRCF NYXH.BR NYXH NYXFF NRIX LOVE JFU JANX ICCT ESPR ELYM DJNJ3.BA DJNJ2.BA ALPN AIH ACOR 0IIM.L 0A8P.L VBIV RCEL NKLA.MX NKLA MRIN FAST FAS.DE ENLV.TA ENLV CLRO AVHHL AVH.AX APVO 8NI.DE 0IKW.L 0HTQ.L 0A3R.L CADL ANAB 0HFQ.L

Read more →
Published at

Apr 8, 2024 11:15 AM

by benzinga.com

mixed

mixed

Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Allarity Therapeutics (NASDAQ:ALLR)

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations.

XXII MDIA LGVN ESPR BYND.CN AUUDW AUUD AEHL 0LHJ.L 0IIM.L VSTRD RELIW RELI NCPL GLMD EPRX.TO MSTR FLGC 0A7O.L

Read more →